It will be a fantastic meeting in Melbourne next year! 😃

Starting today, we're joined by our amazing friends from APACS, the Italian EGPA patient association🩷 We’re truly grateful for their dedication and tireless work to improve the quality of life of patients every single day. So proud to walk this path together✨ #EUVAS2025 #APACS

What a great start to Day 1 of #EUVAS2025! 🌟 Prof. Georg Schett opened the course with a brilliant talk on CAR-T cells and bispecific T-cell engagers in systemic autoimmune diseases — a glimpse into the future of targeted therapies! #AutoimmuneDiseases #CAR_Tcells

𝗗𝗮𝘆 𝟮 of #EUVAS2025 is coming to a close! 🌅 Wrapping up with the study group sessions — including the 𝗙𝗔𝗜𝗥𝗩𝗔𝗦𝗖 𝗺𝗲𝗲𝘁𝗶𝗻𝗴. Great talks, lively discussions & fresh insights into vasculitis. Thanks to all who contributed to such a great day! 🙌

𝗗𝗮𝘆 𝟯 of #EUVAS2025 is going strong! 🚀 After a great plenary on ANCA-associated small vessel vasculitis, we jumped into some very interesting parallel sessions. The plenary is continuing and study group meetings are just around the corner! 🧬💬 #Vasculitis #EESG

𝗗𝗮𝘆 𝟰 of #EUVAS2025 and the congress has come to an end! 💫 A huge thank you to everyone who joined us — it’s been an incredible few days of science, connection, and shared purpose. It was truly amazing. See you next time! #EESG #EUVAS2025

🔦Don't miss the scientific session: "Spotlight on Small Vessel Vasculitis" at #EULAR2025 🧠 Watch experts tackle real cases live. 💬 Compare your treatment approach with the pros. 📍 Thursday, 12 June 2025 | 13:30 CEST | Room B2. Explore more👉bit.ly/4jxLgV5 #EULAR

Prediction modelling in #ANCA #Vasculitis to improve patient education, shared decision-making and therapeutic evaluation, thanks to ERA - European Renal Association and Annette Bruchfeld for highlighting the importance of prognostic tools in optimising patient care at #ERA25 👏👏👏

Don’t miss the latest review published in NatRevRheumatol on advances in the treatment of ANCA-associated vasculitis (AAV) — a must-read update for anyone! pubmed.ncbi.nlm.nih.gov/40473820/ Many thanks to the authors for their valuable contribution! 👏 #AAV #vasculitis

🚨Alert interesting article! 🔥 New study by Sorin et al. in Rheumatology (Oxford) on GC vs GC+CYC in EGPA (without poor prognosis factors) - a valuable addition to the EGPA literature! 📚 #EGPA #vasculitis pubmed.ncbi.nlm.nih.gov/40411755/

#CarersWeek #Vasculitis #caring for young people diagnosed with vasculitis a #raredisease. An increasing number of younger people and children are being diagnosed. This can have an impact on their #schooling, general behaviour and future fertility. vasculitis.org.uk/living-with-va…

🧵[1/2] Dr Georg Schett follow up of 🚗 CAR-T cell therapy pilot cohort ⚡️Now 50 patients under treatment, ⚡️Longest follow up of nearly 5 years ➡️ 72 patients year ⚡️92% remission 96% off drugs 2 relapses #EULAR2025 EULAR

🩺 Pilot study tested personalized rituximab spacing in 19 ANCA vasculitis patients based on individual relapse risk after standard 18-month treatment 📅 High-risk patients continued 6-monthly infusions, intermediate-risk received 12-monthly spacing, and low-risk switched to

📢 Save the date! 𝟏𝟎𝐭𝐡 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 𝐨𝐟 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐄𝐆𝐏𝐀 𝐒𝐭𝐮𝐝𝐲 𝐆𝐫𝐨𝐮𝐩 📍September 18 – Paris 🔹Free course 🔹50 in-person spots: eventi.eve-lab.com/congresso.php?… 🔹100 online spots: eventi.eve-lab.com/congresso.php?… 📄Program: eventi.eve-lab.com/images/congres…

Time is critical in AAV: dampening kidney inflammation prevents damage Why not target effector T cells - leave other T cells alone? Our paper in @NDTSocial defines IL-7Ra as a target doi.org/10.1093/ndt/gf… Anti-IL-7Ra Abs are in Phase 2 trials - alopecia Q32 Bio Inc. ?an AAV therapy

Whether you're coming from across the globe or just hopping over from a nearby city, there’s an itinerary to Melbourne with your name on it! Book now to lock in your Australian adventure. Dive into the ultimate Melbourne guide at melbournecb.com.au/welcome-to-mel… MelbConventionBureau

The 𝟮𝟮𝗻𝗱 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗩𝗮𝘀𝗰𝘂𝗹𝗶𝘁𝗶𝘀 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 is coming in February 2026! 🧪 Calling Early Career Scientists & Clinicians! We're excited to share the July E-zine – full of updates and opportunities you won’t want to miss. mailchi.mp/icmsaust/ivw20…

🌏 𝗣𝗹𝗮𝗻 𝘆𝗼𝘂𝗿 𝘁𝗿𝗶𝗽 𝘁𝗼 𝗠𝗲𝗹𝗯𝗼𝘂𝗿𝗻𝗲! 📷 Over 400 flights arrive in Melbourne every week, so you’re sure to find the perfect itinerary! We’ll be there – will you? 📌 Book early to get the best deals and lock in your Australian adventure: melbournecb.com.au/welcome-to-mel…

Thrilled to share our latest RCT in #EGPA comparing Rituximab Versus Conventional Therapy for Remission Induction, and published in ⁦Annals of Int Med⁩ - Thanks to all the amazing French Vasculitis Study Group 🙏🙏🙏 acpjournals.org/doi/10.7326/AN…